Study of the absorption rate and bioavailability of paracetamol in oral solution;Estudio de la velocidad de absorción y de la biodisponibilidad de paracetamol en solución oral

DOLOR

Volumn 17, Issue 1, 2002, Pages 15-18

  Farré, Magí ^a,b   Roset, P N ^a,b   Pascual, J A ^a,c   Marcos, J ^a   Peiro A M ^a   Abanades, S ^a   Menoyo, E ^a   Sanchez I ^a   Baena, A ^d  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d SL   (Spain)

Author keywords

Absorption; Bioavailability; Healthy volunteers; Paracetamol; Pharmacokinetics

Indexed keywords

PARACETAMOL;

ABSENCE OF SIDE EFFECTS; AREA UNDER THE CURVE; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TOLERABILITY; HUMAN; REVIEW;

EID: 33749493581     PISSN: 02140659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Dollery C (ed). Therapeutic drugs. Vol 2. Edimbourgh: Churchill Livingstone 1991:13-5 (Paracetamol).
2. th ed. Londres: The Pharmaceutical Press 1996:81-5 (Paracetamol).
3. Prescott LF. Acetaminophen (Paracetamol). A critical bibliographic review. Londres: Taylor & Francis, 1996.
4. McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford: Oxford University Press 1998:58-77.
5. Farré M, Hernández-López C, Roset PN. Farmacología del paracetamol: dosis óptima. Dolor 2001;16(Suppl I):5-11.
6. Sanaka M, Kuyama Y, Yamanaka M. Guide for judicious use of the paracetamol absorption technique in a study of gastric emptying rate of liquids. J Gastroenterol 1998;33:785-91.
7. Sanaka M, Koike Y, Yamamoto T, Mineshita S, Yamaoka S, Hirama S, et al. A reliable and convenient parameter of the rate of paracetamol absorption to measure gastric emptying rate of liquids. Int J Clin Pharmacol Ther 1997;35:509-13.
8. Paintaud G, Thibault P, Queneau PE, Magnette J, Berard M, Rumbach L, et al. Intraindividual variability of paracetamol absorption kinetics after a semi-solid meal in healthy volunteers. Eur J Clin Pharmacol 1998;53:355-9.
9. Farré M, Roset PN, Pascual JA, Hernández-López C, Mas M, Marcos J, et al. Estudio de la velocidad de absorción y de la biodisponibilidad de Gelocatil comprimidos 650 mg. Dolor 2001;16:27-32.
10. Rygnestad T, Zahlsen K, Sandal FA. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J Clin Pharmacol 2000;56:141-3.
11. Jackson D. The assessment of tolerance and side-effects in non-patient volunteers. En: O'Grady J, Linet OI (eds). Early phase drug evaluation in man. Londres: MacMillan 1990:195-205.
12. Farré M, Roset PN, Pascual JA, Mas M, Sanagustin J, Menoyo E, et al. Estudio de la biodisponibilidad comparativa de la asociación de paracetamol y codeína (Gelocatil Codeína) frente a un preparado de referencia. Dolor 1999;14:163-71.
13. th ed. Foster City: Chemical Toxicology Institute 1995.
14. Rygnestad T, Zahlsen K, Sandal FA. Absorption of effervescent paracetamol tablets relative to ordinary paracetamol tablets in healthy volunteers. Eur J Clin Pharmacol 2000;56:141-3.
15. Divoll M, Ameer B, Abernethy DR, Greenblatt DJ. Age does not alter acetaminophen absorption. J Am Geriatr Soc 1982;30:240-4.
16. Ameer B, Divoll M, Abernethy DR, Greenblatt DJ, Shargel L. Absolute and relative bioavailability of oral acetaminophen preparations. J Pharm Sci 1983;72:955-8.
17. Ganry HE, Insuasty JH, Vincent FG, Schmidely N. Comparison of effervescent and non effervescent paracetamol based on calculations of rates of pain reduction. J Clin Pharmacol 1996;36:855.
18. Moller PL, Norholt SE, Ganry HE, Insuasty JH, Vincent FG, et al. Time to onset of analgesia and analgesic efficacy of effervescent acetaminophen 1000 mg compared to tablets acetaminophen 1000 mg in postoperative dental pain: a single-dose, double-blind, randomized, placebo-controlled study. J Clin Pharmacol 2000;40:370-8.
19. Sutton JA, Gillin WP, Grattan TJ, Clarke GD, Kilminster SG. A new laser pain threshold model detects a faster onset of action from a liquid formulation of 1 g paracetamol than an equivalent tablet formulation. Br J Clin Pharmacol 2002;53:43-7.